Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Nail Changes in Patients With Psoriatic Disease Treated With Etanercept Using Non- Invasive Optical Coherence Tomography

NCT05135312 is registered in ClinicalTrials.gov with OptiSkin Medical as lead sponsor.

NCT NCT05135312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Nail Changes in Patients With Psoriatic Disease Treated With Etanercept Using Non- Invasive Optical Coherence Tomography
Lead sponsor
OptiSkin Medical
Phase
Phase 4
Overall status
Unknown status
Start date
August 9, 2021
Completion date
August 8, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriatic arthritis, psoriatic nail